Virus incl. Viroids & Prions
SARS-CoV2 (attenuated, vaccination strains)
Strain/Type
sCPD9 & sCPD9-ΔFCS
Source/Company
Vetenerian Institute FUB, Jakob Trimpert & Benedikt Kaufer, Kontakt Dusan Kunec (Dusan.Kunec@fu-berlin.de)
Usage Regulation and Limitations
- for research purposes only
- only for AG Haag, contact of Katharina Achazi required before use
- only testing of new therapeutics
- no vaccine development
How to cite
cite Trimpert J et al. (2021). Cell Rep. 36(5):109493.
Host tropism
human, bat, etc.
Route of Transmission
aerogen (inhalation), air-borne
Characteristics e.g. sensitizing or toxic effects, replication deficiant, not infectious, attenuated, inactivated (upload relevant documents)
causes infection
Approved as biological safety measure if taken as recipient organism for genetic engineering?
no
Genetically modified (GenTSV)
yes, S2
Risk group (BioStoffV)
RG2
Risk assessment
Operation instructions (mandatory for RG2 and higher)
According to ZKBS (888-12-4b LAGeSo-Änderung Genehmigung v. 12.5.22.pdf) and LaGeSo (888-12-4b ZKBS-Stellungnahme v. 5.4.22.pdf)
Occupational health care (according to ArbMedVV)
yes
Storage location of aliquots in the Biolab (just click Bearbeiten in the right corner of the header to add or change information in the table and use the menue in the left header to e.g. add a row)
| source | virus strain | freezing date | virus amount per vial | stock was produced on | no. of aliquots | belongs to (full name) | rack/box in N2 tank or -80°C freezer and location (room, address) | comments |
|---|---|---|---|---|---|---|---|---|
Background
Groenke N et al. (2020). Cell Rep. 31(4):107586.
Trimpert J et al. (2021). Cell Rep. 36(5):109493.
Trimpert J et al. (2021). Sci Adv. 7(49):eabk0172.
Trimpert J et al. (2020). Cell Rep. 8;33(10):108488.
Jackson CB et al. (2021). Biochem Biophys Res Commun. 538:108-115.
Volz E et al. (2021). Cell. 184(1):64-75.e11.
